Toxicities and outcomes for patients with CNS lymphoma (CNSL) consolidated with high-dose therapy and autologous stem cell transplantation (HDT-ASCT) using thiotepa, pharmacokinetically-targeted (PR) busulfan (Bu), cyclophosphamide (TBC) conditioning Meeting Abstract
| Authors: | Scordo, M.; Bhatt, V.; Hsu, M.; Omuro, A. M.; Matasar, M. J.; DeAngelis, L.; Dahi, P.; Moskowitz, C. H.; Giralt, S. A.; Sauter, C. S. |
| Abstract Title: | Toxicities and outcomes for patients with CNS lymphoma (CNSL) consolidated with high-dose therapy and autologous stem cell transplantation (HDT-ASCT) using thiotepa, pharmacokinetically-targeted (PR) busulfan (Bu), cyclophosphamide (TBC) conditioning |
| Meeting Title: | 2016 BMT Tandem Meetings |
| Journal Title: | Biology of Blood and Marrow Transplantation |
| Volume: | 22 |
| Issue: | 3 Suppl. 1 |
| Meeting Dates: | 2016 Feb 18-22 |
| Meeting Location: | Honolulu, HI |
| ISSN: | 1083-8791 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2016-03-01 |
| Start Page: | S132 |
| End Page: | S133 |
| Language: | English |
| ACCESSION: | WOS:000370910300160 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.bbmt.2015.11.465 |
| Notes: | Meeting Abstract: 155 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
